Robbins Arroyo LLP: INC Research Holdings, Inc. (INCR) Misled Shareholders According to a Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against INC Research Holdings, Inc. (NasdaqGS: INCR) on behalf of all purchasers of INC securities between May 10, 2017 and November 9, 2017, for alleged violations of the Securities Exchange Act of 1934 by INC's officers and directors. INC, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.

View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/inc-research-holdings-inc/

INC Research Accused of Misleading Investors About Its Merger

According to the complaint, on August 1, 2017, INC announced that it merged with inVentiv Health, Inc., representing the merger as "the beginning of an industry-changing new company." However, the merger did not provide the benefit that INC officials represented because inVentiv was underperforming. On November 9, 2017, INC reported Q3 2017 results that fell far below investors' expectations, including a net loss from operations of $88.9 million, compared to income from operations of $39.4 million for Q3 2016. INC attributed the poor results to merger-related transaction expenses of $84.3 million, an impairment charge of $30 million with respect to the INCR trademark intangible asset, and an increase in amortization expense of $41.9 million due to the acquisition of intangible assets from the merger. These results drew criticism from a William Blair analyst, who called the financial results "sloppy" and "worrisome" and noted negative implications for the company's revenues. On this news, INC's stock fell $16.35 per share, or over 28%, to close at $41.15 per share on November 9, 2017.

INC Research Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, [email protected], or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171215005874/en/

Robbins Arroyo LLP
Leonid Kandinov
(619) 525-3990 or Toll Free (800) 350-6003
[email protected]
www.robbinsarroyo.com